Skip to main content
. 2018 Sep 11;2(17):2254–2261. doi: 10.1182/bloodadvances.2018021899

Table 1.

Patients’ characteristics

Measure All patients, N = 242
Sex, n (%)
 Male 123 (51)
 Female 119 (49)
Median age (range), y 57.8 (9.3-79.6)
White, n (%)
 Yes 182 (75)
 No 60 (25)
Diagnosis, n (%)
 AML 206 (85)
 MDS/AML 23 (10)
 MPD/AML 10 (4)
 MDS 3 (1)
Disease status at MUD search, n (%)
 Remission 113 (47)
 Not in remission 128 (53)
 Missing 1 (0.4)
Reason not in remission, n (%)
 PIF 35 (28)
 Relapsed/refractory 43 (34)
 Newly diagnosed 50 (39)
Haplotype frequency, n (%)
 Common 190 (79)
 Uncommon 52 (21)
10/10 MUD identified, n (%)
 Yes 160 (66)
 No 82 (34)
Transplant type, n (%)
 MUD 85 (35)
 Other 66 (27)
 None 91 (38)
Reason for not receiving a transplant, n (%)
 Disease progression 36 (15)
 Refractory 19 (8)
 Other 36 (15)
Median time to SCT from MUD search date (range), mo
 10/10 MUD (n = 85) 2.9 (1.4-13.0)
 MRD (n = 15) 2.3 (1.6-6.4)
 9/10 MUD (n = 9) 4.6 (3.7-13.1)
 Haploidentical (n = 20) 3.5 (0.9-13.4)
 UCB (n = 22) 3.2 (1.7-14.7)

MPD, myeloproliferative disorder; SCT, stem cell transplant.